Uptake of 99mTc-phytate in osteosarcoma cases

During routine liver spleen scintigraphic studies using 99mTc-phytate in patients with proven osteosarcoma, an unusual uptake of this radiopharamaeutical at the primary site was observed. In all, five cases have been investigated and we have observed the uptake of 99mTc-phytate at the primary tumor...

Full description

Saved in:
Bibliographic Details
Published in:European Journal of Nuclear Medicine 1989, Vol.15 (3), p.162-164
Main Authors: NAGESWARA RAO, P, MURTHY, S. N, SIDDALINGA DEVARU, KRISHNA BHARGAVA, M, JOGAIAH, N. H
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Bone Neoplasms - diagnostic imaging
Bone Neoplasms - secondary
Diseases of the osteoarticular system
Female
Humans
Liver Neoplasms - diagnostic imaging
Liver Neoplasms - secondary
Medical sciences
Organometallic Compounds
Organotechnetium Compounds
Osteosarcoma - diagnostic imaging
Phytic Acid
Radionuclide Imaging
Technetium
Tumors of striated muscle and skeleton
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:During routine liver spleen scintigraphic studies using 99mTc-phytate in patients with proven osteosarcoma, an unusual uptake of this radiopharamaeutical at the primary site was observed. In all, five cases have been investigated and we have observed the uptake of 99mTc-phytate at the primary tumor site. Early and delayed imaging showed persistant concentration of the radiopharmaceutical. Studies with 99mTc-sulfur colloid in one of the patients did not show any uptake at the tumor site.
ISSN:0340-6997
1619-7089
DOI:10.1007/BF00254631